Hologic Inc (HOLX)

44.69
0.11 0.25
NASDAQ : Health Care
Prev Close 44.58
Open 44.62
Day Low/High 44.45 / 44.80
52 Wk Low/High 31.84 / 43.00
Volume 363.89K
Avg Volume 2.36M
Exchange NASDAQ
Shares Outstanding 279.30M
Market Cap 12.46B
EPS 1.20
P/E Ratio 38.12
Div & Yield N.A. (N.A)

Latest News

Cramer: The Best Performers Show No Signs of Letting Up

Cramer: The Best Performers Show No Signs of Letting Up

Their overseas business has been carrying them.

Cramer: We Have Nothing to Distinguish the Stocks Right Now

Cramer: We Have Nothing to Distinguish the Stocks Right Now

We know that we are in the era when index managers are ascendant.

Hologic Completes Acquisition Of Cynosure

Hologic Completes Acquisition Of Cynosure

-- Transaction Provides Entry into Large, Fast-Growing Medical Aesthetics Market, Boosts Hologic's Growth Rate --

Cramer: Top 10 Bull Markets Right Now (Part 1)

Cramer: Top 10 Bull Markets Right Now (Part 1)

Bull market number one, perhaps of all time: the financials.

Cramer: Top 10 Bull Markets Right Now

Cramer: Top 10 Bull Markets Right Now

Bull market number one, perhaps of all time: the financials.

Medtronic Earnings Rebound in Third Quarter, Shares Climb

Medtronic Earnings Rebound in Third Quarter, Shares Climb

The company discusses potential share repurchases and its acquisition strategy.

Deals of the Week: Valentine Couplings and Breakups

Deals of the Week: Valentine Couplings and Breakups

SoftBank's $3.3 billion deal for Fortress topped the notable transactions this week.

Hologic Moves Up In Analyst Rankings, Passing Marsh & McLennan Companies

Hologic Moves Up In Analyst Rankings, Passing Marsh & McLennan Companies

In a study of analyst recommendations at the major brokerages, for the underlying components of the S&P 500, Hologic, Inc. has taken over the #121 spot from Marsh & McLennan Companies Inc.

FDA Grants PMA Approval For Hologic's Aptima® Hepatitis C Quant Dx Assay

FDA Grants PMA Approval For Hologic's Aptima® Hepatitis C Quant Dx Assay

HCV viral load test now available alongside HIV-1 assay and women's health menu on the fully automated Panther system

Wall Street Smashes Records for Fourth Day in a Row After Rocky Session

Wall Street Smashes Records for Fourth Day in a Row After Rocky Session

Wall Street smashes records again on Tuesday, closing at all-time highs for its fourth consecutive session.

Stocks Find Upward Momentum Again as Chances of a Rate Hike Rise

Stocks Find Upward Momentum Again as Chances of a Rate Hike Rise

Wall Street hold small gains on Tuesday after Federal Reserve Chair Janet Yellen plays the part of both dove and hawk.

Stocks Mixed as Fed's Yellen Talks Rates on Capitol Hill

Stocks Mixed as Fed's Yellen Talks Rates on Capitol Hill

Wall Street is mixed on Tuesday morning after Federal Reserve Chair Janet Yellen champions the strength of the U.S. economy.

Hologic To Acquire Cynosure, Leader In Medical Aesthetics Systems And Technologies, In All-Cash Tender Offer That Combines Two Complementary Businesses

Hologic To Acquire Cynosure, Leader In Medical Aesthetics Systems And Technologies, In All-Cash Tender Offer That Combines Two Complementary Businesses

-Expands Hologic's Scientific and Commercial Expertise into Large, Adjacent Medical Device Segment Growing at Double-Digit Rate -

The S&P 500 Companies With the Most Diverse Boards

The S&P 500 Companies With the Most Diverse Boards

The most ethnically and gender diverse boards may surprise you.

Hologic Launches Next-Generation NovaSure® ADVANCED Global Endometrial Ablation System For The Treatment Of Abnormal Uterine Bleeding

Hologic Launches Next-Generation NovaSure® ADVANCED Global Endometrial Ablation System For The Treatment Of Abnormal Uterine Bleeding

--Smaller 6 mm Diameter and Product Updates Are Designed to Enhance Patient Comfort and Improve Physician Ease-of-Use--

Hologic Completes Divestiture Of Blood Screening Business

Hologic Completes Divestiture Of Blood Screening Business

- Strengthens Efforts to Build a Sustainable Growth Company -

Analysts' Actions -- Agco, AthenaHealth, Oshkosh, Hologic and More

Analysts' Actions -- Agco, AthenaHealth, Oshkosh, Hologic and More

Here are Wednesday's top research calls, including upgrades for Agco, AthenaHealth and Hologic, and a downgrade for Oshkosh.

FDA Grants PMA Approval For Hologic's Aptima® HIV-1 Quant Assay

FDA Grants PMA Approval For Hologic's Aptima® HIV-1 Quant Assay

--High-performing HIV viral load test now available alongside broad women's health menu on the fully automated Panther® system--

Hologic Agrees to Sell Blood Screening Business to Grifols for $1.85B

Hologic Agrees to Sell Blood Screening Business to Grifols for $1.85B

Hologic and Grifols have worked together since 1998 building a blood screening business, and now Hologic will sell its share to Grifols.